Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
CNSP on Nasdaq
Christopher Downs - trading volume in the past year for CNS Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common stock |
103K |
$31K |
$0.30 |
Feb 1, 2024 |
Direct |
|
|
Restricted Stock Units |
242 |
$72.50 |
$0.30 |
Apr 8, 2024 |
Direct |
Common Stock |
|
Series B Warrant to purchase common stock |
162K |
|
|
Feb 1, 2024 |
Direct |
Common Stock |
|
Series A Warrant to purchase common stock |
94.9K |
|
|
Feb 1, 2024 |
Direct |
Common Stock |
|
Option to purchase common stock |
202 |
|
|
Apr 8, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.